BMS-844421 / Ionis, BMS  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BMS-844421 / Ionis, BMS
NCT01082562: Safety Study of BMS-844421 for Treatment of Hypercholesterolemia

Terminated
1
40
Europe
BMS-844421, 0.9% sodium chloride injection solution
Bristol-Myers Squibb
Atherosclerosis, Hypercholesterolemia
07/10
07/10

Download Options